QQQJ
Invesco NASDAQ Next Gen 100 ETF
QQQJ tracks a modified market-cap-weighted, narrow index of 100 non-financial stocks that are next-eligible for inclusion in the NASDAQ-100 Index.
US
EQUITY
Rules-Based
MANAGEMENT STYLE
$ 1.1 B
ASSETS UNDER MGMT
15 bp
EXPENSES
Fund Basics
| Inception date | Oct 13, 2020 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | Quarterly |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | Yes |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| NATERA INC | 3.0 % |
| EBAY INC | 2.7 % |
| REVOLUTION MEDICINES, INC. | 2.1 % |
| ELBIT SYSTEMS LTD | 2.0 % |
| NETAPP INC | 2.0 % |
| BIOGEN IDEC INC | 1.9 % |
| STEEL DYNAMICS INC | 1.8 % |
| KIMBERLY-CLARK CORP | 1.8 % |
| ILLUMINA INC | 1.8 % |
| OKTA, INC. CLASS A | 1.8 % |
Constituent Breakdown
| Number of holdings | 106 |
| Herfindahl-Hirschman Index | 140 |
| Wgt avg mkt cap (mns) | $25,164 |
| Large cap (>$10bn) | 92.1% |
| Mid cap ($2-10bn) | 3.6% |
| Small cap (<$2bn) | 0.1% |
| Developed mkts. | 93.6% |
| Emerging mkts. | 2.0% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 80.3 % |
 |
ISRAEL | 3.7 % |
 |
SINGAPORE | 2.2 % |
 |
AUSTRALIA | 2.0 % |
 |
CHINA | 1.9 % |
 |
IRELAND | 1.4 % |
 |
BRITAIN | 1.4 % |
 |
NETHERLANDS | 1.2 % |
 |
SWITZERLAND | 0.7 % |
 |
GERMANY | 0.5 % |
Historical Performance
Standardized Performance (as of 09/30/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 19.0% | 22.5% | 20.2% | 21.2% | 5.8% | -- | -- | 8.6% |
| Dividend Yield | 0.7% | 1.0% | 1.0% | 1.0% | 1.0% | -- | -- | 0.9% |
| Total Returns | 19.7% | 23.5% | 21.2% | 22.2% | 6.8% | -- | -- | 9.5% | Ann. Volatility | 20.1% | 19.6% | 20.3% | 19.0% | 22.2% | -- | -- | 21.8% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 1.29 | 73% |
| MSCI EAFE | 0.91 | 54% |
| MSCI Emg Mkts | 0.57 | 55% |
Liquidity Measures
| Avg. volume (000) | 154 |
| ADV traded (mns) | $7 |
| Turnover | 0.6% |
| Avg. Bid/Ask (% of price) | 0.04% |
Technical Indicators
| 30d moving avg. (EMA) | $44.32 |
| Relative strength (RSI) | 48 |
| MACD/Signal | -0.08/-0.06 |
| Bollinger Bands (Upper/Lower) | $45.22/$43.32 |
| Short interest (% of AUM) | 0.5% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. QQQJ |
Expenses vs. QQQJ |
ALTAR Score™ vs. QQQJ |
|---|---|---|---|---|
| TMFX | Motley Fool Next Index ETF | 20.8% | +35 bp | -1.0% |
| VBK | Vanguard Small-Cap Growth ETF | 19.2% | -10 bp | -2.3% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 18.9% | +4 bp | -4.8% |
| IBB | iShares Biotechnology ETF | 18.4% | +29 bp | -5.2% |
| BBH | VanEck Biotech ETF | 16.5% | +20 bp | -1.3% |
| TAX | Cambria Tax Aware ETF | 15.8% | +39 bp | +1.3% |
| RSPT | Invesco S&P 500 Equal Weight Technology ETF | 15.0% | +25 bp | +1.8% |
| FTC | First Trust Large Cap Growth AlphaDEX Fund | 14.8% | +43 bp | -1.1% |
| FLQM | Franklin U.S. Mid Cap Multifactor Index ETF | 14.8% | +15 bp | +4.0% |
| IWP | iShares Russell Mid-Cap Growth ETF | 14.7% | +8 bp | -0.4% |
Risk and Returns: QQQJ vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 11/6/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
4.4%
ALTAR SCORE™
27th
PERCENTILE
UNDERWEIGHT
ETFRC RATING
There are 1,388 funds in the US Equity category with an average
ALTAR Score™ of 5.7% and a standard deviation
of 2.1%. QQQJ's ALTAR Score™ is approximately -0.6 standard
deviations above the category average. This places QQQJ in the 27th percentile
among funds in the category.
Sell-Side Consensus
$54.24
PRICE TARGET
+28.0%
UPSIDE